中国·威尼斯(37000cm-VIP认证)网站-Made in China

姓名：刘代红

导师类别：博士生导师

专业：内科血液学

一、教育经历

1985.7-1990.7：大连医科大学医疗系英文班医学学士

1992.9-1995.7：北京大学血液病研究所临床技能型研究生医学硕士1999.7-2001.9：德国海德堡大学医学博士(M.D.)

二、工作经历

1990.8-1992.8：沈阳37000cm威尼斯附属二院普通内科住院医师

1995.8-1999.6：北京大学人民医院住院医师、大内科住院总医师、主治医师

2001.10-2014.9：北京大学主治医师、副主任医师、主任医师、副教授

2013.12:博士生导师

2014.9-2016.12：解放军总医院血液科主任医师、副教授

2016.12-至今：解放军总医院血液科主任医师、教授

三、研究方向（包括承担课题项目）

研究方向

1．重症/恶性血液病的诊治

2．造血干细胞移植

承担课题项目：

1．国家临床重点专科军队建设项目（临床专业）：2016.01- 2018.12

2．中国抗癌协会继教育科技服务部项目：2015-2016，早期分子学反应在慢性髓系白血病患者酪氨酸激酶抑制剂治疗中的预后指导意义的研究

3.中国抗癌协会：同胞全合的异基因造血干细胞移植中福达拉滨替代改良BUCy方案中环磷酰胺的随机对照研究

4.985项目，血液恶性肿瘤的诊治，985-2-115-112，2008-12-1~2010-12-1

5.863计划，HLA不合造血干细胞移植方法的建立与完善，2006AA02Z4AO，2006-12-1~2008-12-31

6.国家杰出青年科学基金，血液与淋巴系统内科学，30725038，2008-1-1~2011-12-1

四、学术兼职

1.全军医学科委会血液专业委员会常委兼秘书长

2.北京医学会血液分会常委

3.中国医药教育协会感染疾病专业委员会常委

4.中国免疫学会血液免疫分会委员

5.中华医学会血液学分会移植学组委员

五、代表性论文著述（限10篇）

1.Lu Wang, Dai-Hong Liu. Tyrosine Kinase Inhibitor for Treatment of Adult Allogeneic Hematopoietic Stem Cell Transplantation Candidate with Philadelphia-Positive Acute Lymphoblastic Leukemia. Chinese Medical Journal. January 20, 2017 (130:2)

2.Li HH, Li F, Gao CJ, Huang WR, Bo J, Dou LP, Wang LL, Jing Y, Wang L, Li WJ, Yu L, Liu DH.Similar incidence of severe acute GVHD and less severe chronic GVHD in PBSCT from unmanipulated, haploidentical donors compared with that from matched sibling donors for patients with haematological malignancies.Br J Haematol. 2016 Oct 7.

3.Huang WR, Li HH, Gao CJ, Bo J, Li F, Dou LP, Wang LL, Jing Y, Wang L, Liu DH, Yu L. Haploidentical, unmanipulated G-CSF-primed peripheral blood stem cell transplantation for high-risk hematologic malignancies: an update. Bone Marrow Transplant. 2016 Jun 20.

4.Liu DH, Xu LP, Zhang XH, Wang Y, Yan CH, Wang JZ, Wang FR, Sun YQ, Ji Y, Zhang YY, Liu KY, Huang XJ. Substitution of cyclophosphamide in the modified BuCy regimen with fludarabine is associated with increased incidence of severe pneumonia: a prospective, randomized study. Int J Hematol. 2013 Dec;98(6):708-15.

5.Liu DH, Xu LP, Liu KY, Wang Y, Chen H, Han W, Zhang XH, Yan CH, Zhang YY, Wang JZ, Chen YH, Wang FR, Huang XJ. Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemia. Bone Marrow Transplant. 2013 Jul 29.

6.Yan CH, Liu DH, Liu KY, Xu LP, Liu YR, Chen H, Han W, Wang Y, Qin YZ, Huang XJ. Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Blood. 2012 Apr 5;119(14):3256-62.

7.Yu Wang#, MD; Dai-Hong Liu#, MD; Kai-Yan Liu, MD; Lan-Ping Xu, MD; Xiao-Hui Zhang, MD; Wei Han, MD; Huan Chen, MD; Yu-Hong Chen, MD; Feng-Rong Wang, MD; Jing-Zhi Wang, MD; Yu-Qian Sun, MD; Xiao-Jun Huang, MD. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in-vitro T-cell-depletion for the treatment of leukemia: nine years of experience at a single center. Cancer. 2013 Mar 1;119(5):978-85.

8.Liu DH, Zhao XS, Chang YJ, Liu YK, Xu LP, Chen H, Han W, Chen YH, Wang Y, Huang XJ. The Impact of Graft Composition on Clinical Outcomes in Pediatric Patients Undergoing Unmanipulated HLA-Mismatched/Haploidentical Hematopoietic Stem Cell Transplantation.Pediatr Blood Cancer. 2011 Jul 15;57(1):135-41.

9.Dai-Hong Liu, Xiao-Jun Huang, Kai-Yan Liu, Lan-Ping Xu, Yu-Hong Chen, Yu Wang, Wei Han, Huan Chen. The safety of recombinant human thrombopoietin in adults after related haploidentical hematopoietic stem cell transplantation, A pilot study. Short Communication. Clinical Drug Investigation. 2011, 31(1): 1-7.

10.Daihong Liu, Chenhua Yan, Lanping Xu et al. Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines. Biol Blood Marrow Transplant. 2010, 16:1567-1575.

六、联系方式

1．通讯地址：北京市海淀区复兴路28号解放军总医院

2．电话：010-55499136

3． E-mail：daihongrm@163.com